Stock comparison
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
IDXX is larger
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B).
Market value leader
IDXX
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B).
Revenue leader
IDXX
IDXX: $4.30B vs NTLA: $67.67M.
Profit leader
IDXX
IDXX: $1.06B vs NTLA: -$412.69M.
Margin leader
IDXX
IDXX: 24.6% vs NTLA: -609.9% net margin.
| Metric | IDXX | NTLA |
|---|---|---|
| Market cap | $44.06 B | $2.16 B |
| US-listed rank | #358 | #2076 |
| Revenue (latest FY) | $4.30B | $67.67M |
| Net income (latest FY) | $1.06B | -$412.69M |
| Net margin | 24.6% | -609.9% |
| P/E (trailing FY) | 41.6x | - |
| SEC filings | 2,148 | 679 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B).
In their latest fiscal years, IDEXX LABORATORIES INC /DE reported $4.30B in revenue while Intellia Therapeutics, Inc. reported $67.67M.
Full pages: IDEXX LABORATORIES INC /DE and Intellia Therapeutics, Inc., or browse the full rankings.